New cream aims to tame burn scars – trial underway
NCT ID NCT06807021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a cream containing FS2 (kynurenic acid) to see if it can reduce scarring in burn patients who need skin grafts. About 70 people aged 12 to 65 will apply the cream or a placebo to both the graft and donor sites for 90 days. The goal is to check safety and whether scars look better with FS2.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FS2 (kynurenic acid) cream
- What this could lead to
- If it works, this could offer a simple cream to reduce scarring after burn surgery, improving appearance and skin function.
- What could go wrong
- This is an early-to-mid stage trial with only 70 participants. The cream may not reduce scars better than the control, and results may not apply to all burn types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURN SCAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Burn Research - Hamilton Health Sciences
RECRUITINGHamilton, Ontario, L8L 2X2, Canada
-
University of Alberta, Division of Plastic Surgery
RECRUITINGEdmonton, Alberta, T6G 2B7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.